An interventional study of revision surgery in Weight Loss, Bariatric Surgery Candidate and Comorbidities and Coexisting Conditions, sponsored by General Committee of Teaching Hospitals and Institutes, Egypt. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-16.
Sponsored by General Committee of Teaching Hospitals and Institutes, Egypt · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Weight Loss with a site in Egypt — 4 open to participants now, 4 under way, none of them phase 3. Weight Loss · Egypt.
Among the 11 studies in Weight Loss with a site in Egypt, this one is one of 2 that started in 2023, is one of 7 with no phase, and was the 4th registered.
1,821 studies on the registry are indexed under Weight Loss; 299 are open to participants now.
Browse Weight Loss studies →4 of the 11 studies in Weight Loss with a site in Egypt are open now. Recruiting first, the newest first:
Badr University · Sites in Egypt
Ages 36–58
General Committee of Teaching Hospitals and Institutes, Egypt · Sites in Egypt
Ages 18–65
Cairo University · Sites in Egypt
Ages 65–75
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 200 Weight Loss studies recruiting now, 74 (37%) set no upper age limit and 109 (55%) stop at 75 or younger; 21 take children under 18; 57 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 2 started in 2023.
This study's planned enrollment of 234 is above the median of 80 across 1,567 interventional studies indexed under Weight Loss.
Median enrollment 150 across the 9 interventional studies, 660 across the 2 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 11 has an industry lead sponsor. The 7 most frequent:
General Committee of Teaching Hospitals and Institutes, Egypt is the lead sponsor of 32 studies on the registry; 11 are open to participants now.
General Committee of Teaching Hospitals and Institutes, Egypt has 4 studies filed under Weight Loss — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 11 studies in Weight Loss with a site in Egypt, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Assess what revisional surgery is superior and provides the best weight loss after primary LSG. What is the occurrence of complications and the nutritional laboratory status? And if the resolution and /or improvement of associated medical problems after the weight loss will occur.
Laparoscopic sleeve gastrectomy (LSG) gained popularity and has become one of the most performed weight loss procedures worldwide. In the long-term follow-up, the literature states that the incidence of gastroesophageal reflux disease (GERD) accounts for 16%, and weight regains accounting for 70% after LSG. These are the two most common complications which can necessitate further surgical intervention.
The hypotheses are that laparoscopic conversion from LSG to Single anastomosis duodeno-ileal bypass (SADI-S), Roux-en-Y gastric bypass (RYGB), or one anastomosis gastric bypass (OAGB) will provide a new significant weight loss, improvement in obesity-related health problems and provide no nutritional deficiency in all cases.
Since the three types of procedures have other anatomical presentations, whereby these is not well tested next to each other in a blinded, controlled setting for the patient, this study is designed to discover if the procedures are superior to each other or not and what the best outcome is for the patient.
A sample size is calculated and with a medium effect size of 0.5 corresponds to a mean difference in %EBMIL between SADI-S, RYGB, and OAGB of at least 10%. Using a power of 0.8 with an alpha of 0.05 resulted in a sample size of 64 patients per group.
Considering a possible loss of patients to follow-up, an additional 20% increase in sample size was included per group, resulting in a minimum of 78 patients per group.
(Total of 3 groups together of 234 patients).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Weight regain
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
After failed sleeve, the patients will get a revisional procedure. The RYGB
Procedure: revision surgery
After failed sleeve, the patients will get a revisional procedure. The OAGB
Procedure: revision surgery
After failed sleeve, the patients will get a revisional procedure. The SADI-S
Procedure: revision surgery
revision procedure after failed sleeve gastrectomy
The number of participants who will have early complications related to surgery
the incidence of re-operation, bleeding or leakages
Time frame: 6 weeks
The percentage Excess body weight loss (%EWL)
the amount of weight loss after revision surgery
Time frame: 3,6,12,24 months
somscore of food tolerance
validated food tolerance questions: Food tolerance (FT) was evaluated using a one-page questionnaire divided into 4 sections, 3 of which were used to calculate the score: overall patient satisfaction with eating (score: 1-5); tolerability to certain food types (score: 0-16); and frequency of vomiting/regurgitation (score: 0-6), with a total score between 1 and 27; higher scores indicate better food tolerance
Time frame: 2,6 weeks and 3,6,12,24 months
Nutritional levels of albuminemia
the albuminemia level will be tested after surgery (g/dl)
Time frame: 3,6,12,24 months
Nutritional levels of proteinemia
the proteinemia level will be tested after surgery (mg/dl)
Time frame: 3,6,12,24 months
Nutritional levels of anemia
the anemia level will be tested after surgery (Mcl)
Time frame: 3,6,12,24 months
Nutritional levels of calcemic
the calcemic level will be tested after surgery (mg/dl)
Time frame: 3,6,12,24 months
Incidence of Reflux
GERD assessment
Time frame: 3,6,12,24 months
The number of participants who will have late complications related to surgery
the incidence of re-operations will be collected
Time frame: 3,6,12,24 months
Short Form 36 Quality of life
Quality of life assessment will be tested 8 chapters with in total 36 questions and a somscore from 0-100 will be calculated (the higher the somscore the better the quality of life is).
Time frame: 3,6,12,24 months
VAS/NRS (incidence of pain)
pain scoring from 0-10 (0 is no pain 10 is most worst pain)
Time frame: 3,6,12,24 months
Metabolic biomarkers Glucagon-like peptide-1 (GLP1)
the GLP1 level will be tested after surgery (mg/ml)
Time frame: 3,6,12,24 months
Metabolic biomarkers Leptin
the Leptin level will be tested after surgery (mg/ml)
Time frame: 3,6,12,24 months
Metabolic biomarkers Peptide YY ( PYY)
the PYY level will be tested after surgery (pg/ml)
Time frame: 3,6,12,24 months
Metabolic biomarkers Ghrelin
the Ghrelin level will be tested after surgery (mg/ml)
Time frame: 3,6,12,24 months
Metabolic biomarkers Insulin
the Insulin level will be tested after surgery (million units/ml)
Time frame: 3,6,12,24 months
The number of participants who will have late complications related to surgery
the incidence of re-operations or complications will be collected
Time frame: 60 months
The number of participants whereby revision surgery necessary after the RCT
the incidence of re-operations or other procedure will be collected
Time frame: 60 months
The percentage Excess body weight loss (%EWL)
the amount of weight loss after revision surgery
Time frame: 60 months
Incidence of Reflux
GERD classification
Time frame: 60 months
Nutritional levels of albuminemia
the albuminemia level will be tested after surgery (g/dl)
Time frame: 60 months
Nutritional levels of proteinemia
the proteinemia level will be tested after surgery (mg/dl)
Time frame: 60 months
Nutritional levels of anemia
the anemia level will be tested after surgery (Mcl)
Time frame: 60 months
Nutritional levels of calcemic
the calcemic level will be tested after surgery (mg/dl)
Time frame: 60 months
Somscore of food tolerance
validated food tolerance questions: Food tolerance (FT) was evaluated using a one-page questionnaire divided into 4 sections, 3 of which were used to calculate the score: overall patient satisfaction with eating (score: 1-5); tolerability to certain food types (score: 0-16); and frequency of vomiting/regurgitation (score: 0-6), with a total score between 1 and 27; higher scores indicate better food tolerance
Time frame: 60 months
Short Form 36 Quality of life
Quality of life assessment will be tested 8 chapters with in total 36 questions and a somscore from 0-100 will be calculated (the higher the somscore the better the quality of life is).
Time frame: 60 months
VAS/NRS (incidence of pain)
pain scoring from 0-10 (0 is no pain 10 is most worst pain)
Time frame: 60 months
Metabolic biomarkers Glucagon-like peptide-1 (GLP1)
the GLP1 level will be tested after surgery (mg/ml)
Time frame: 60 months
Metabolic biomarkers Leptin
the Leptin level will be tested after surgery (mg/ml)
Time frame: 60 months
Metabolic biomarkers Peptide YY ( PYY)
the PYY level will be tested after surgery (pg/ml)
Time frame: 60 months
Metabolic biomarkers Ghrelin
the Ghrelin level will be tested after surgery (mg/ml)
Time frame: 60 months
Metabolic biomarkers Insulin
the Insulin level will be tested after surgery (million units/ml)
Time frame: 60 months
Plan to share: Yes — FAIR data of this study can be requested. All will be saved in the Castor Electronic data capture system.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: After 2 and 5 years and after full analysis and publication the data will be available and stored for minimal 10 years.
Access criteria: Email the Principal investigator. Whereby access to an annonymous database site will be created.
Started Mar 2023 (actual). Primary completion is estimated for Mar 2028, 60 months after the start.
Of 671 non-industry interventional studies with no phase under Weight Loss, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 60 months is above that.
Counting every sponsor, half of 730 studies reached it within 24 months; a quarter within 11 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
General Committee of Teaching Hospitals and Institutes, Egypt